Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy

Clinical trial NCT06711523 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06711523
Sponsor: Kexing Biopharm Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Neutropenia, Chemotherapy-Induced Febrile Breast Neoplasm Female

Start date: 2025-01-09
Primary completion: 2026-06-30
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.